6 Einträge gefunden

1. Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target

   1. Farschtschi, Said
   2. Kluwe, Lan
   3. Park, Su-Jin
   4. Oh, Su-Jun
   5. Mah, Nancy
   6. Mautner, Victor-Felix
   7. Kurtz, Andreas

   2020 - Forschungsinformationssystem des UKE
2. Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients

   1. Farschtschi, Said
   2. Park, Su-Jin
   3. Sawitzki, Birgit
   4. Oh, Su-Jun
   5. Kluwe, Lan
   6. Mautner, Victor F
   7. Kurtz, Andreas

   2016 - Forschungsinformationssystem des UKE
3. Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo

   1. Wei, Jiang
   2. Freytag, Marcus
   3. Schober, Yvonne
   4. Nockher, Wolfgang A
   5. Mautner, Viktor-Felix
   6. Friedrich, Reinhard E
   7. Manley, Paul W

   2014 - Forschungsinformationssystem des UKE - frei zugänglich
4. Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors

   1. Park, Su-Jin
   2. Sawitzki, Birgit
   3. Kluwe, Lan
   4. Mautner, Victor-Felix
   5. Holtkamp, Nikola
   6. Kurtz, Andreas

   2013 - Forschungsinformationssystem des UKE - frei zugänglich
5. Cancer stem cell-like cells derived from malignant peripheral nerve sheath tumors.

   1. Spyra, Melanie
   2. Kluwe, Lan
   3. Hagel, Christian
   4. Nguyen, Rosa
   5. Panse, Jens
   6. Kurtz, Andreas
   7. Mautner, Viktor Felix

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
6. Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model.

   1. Demestre, Maria
   2. Herzberg, Jan
   3. Holtkamp, Nikola
   4. Hagel, Christian
   5. Reuss, David
   6. Friedrich, Reinhard E
   7. Kluwe, Lan

   2010 - Forschungsinformationssystem des UKE